Oxytocin, vasopressin, and human social behavior

Frontiers in Neuroendocrinology

Volumn 30, Issue 4, 2009, Pages 548-557

  Heinrichs, Markus ^a   von Dawans, Bernadette ^a   Domes, Gregor ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Affiliation; Anxiety; Approach behavior; Arginine vasopressin; Attachment; Neuropeptides; Oxytocin; Psychobiological therapy; Social behavior; Stress

Indexed keywords

ARGIPRESSIN; OXYTOCIN; OXYTOCIN RECEPTOR; PLACEBO; VASOPRESSIN RECEPTOR;

AGGRESSION; ANXIETY; AUTISM; CHILD ABUSE; CLINICAL TRIAL; COGNITION; DEPRESSION; GENETIC ASSOCIATION; HORMONE ACTION; HUMAN; NEUROMODULATION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL PHOBIA; SOCIAL STRESS; SOCIAL SUPPORT;

ANIMALS; ANXIETY; ARGININE VASOPRESSIN; AUTISTIC DISORDER; COGNITION; HUMANS; INTERPERSONAL RELATIONS; MENTAL DISORDERS; OXYTOCIN; SOCIAL BEHAVIOR; SOCIAL PERCEPTION;

EID: 70149117023     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2009.05.005     Document Type: Review

References (167)

1. Adolphs R. Cognitive neuroscience of human social behaviour. Nature Reviews Neuroscience 4 (2003) 165-178
2. Agrawal H.R., Gunderson J., Holmes B.M., and Lyons-Ruth K. Attachment studies with borderline patients: a review. Harvard Review of Psychiatry 12 (2004) 94-104
3. Altemus M., Deuster P.A., Galliven E., Carter C.S., and Gold P.W. Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lactating women. Journal of Clinical Endocrinology and Metabolism 80 (1995) 2954-2959
4. Altemus M., Jacobson K.R., Debellis M., Kling M., Pigott T., Murphy D.L., and Gold P.W. Normal CSF oxytocin and NPY levels in OCD. Biological Psychiatry 45 (1999) 931-933
5. Altemus M., Pigott T., Kalogeras K.T., Demitrack M., Dubbert B., Murphy D.L., and Gold P.W. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Archives of General Psychiatry 49 (1992) 9-20
6. Altemus M., Redwine L.S., Leong Y.M., Frye C.A., Porges S.W., and Carter C.S. Responses to laboratory psychosocial stress in postpartum women. Psychosomatic Medicine 63 (2001) 814-821
7. Amico J.A., Johnston J.M., and Vagnucci A.H. Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women. Endocrine Research 20 (1994) 79-87
8. Anderberg U.M., and Uvnas-Moberg K. Plasma oxytocin levels in female fibromyalgia syndrome patients. Zeitschrift für Rheumatologie 59 (2000) 373-379
9. Anderson G.M. Report of altered urinary oxytocin and AVP excretion in neglected orphans should be reconsidered. Journal of Autism and Developmental Disorders 36 (2006) 829-830
10. Ansseau M., Legros J.J., Mormont C., Cerfontaine J.L., Papart P., Geenen V., Adam F., and Franck G. Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology 12 (1987) 231-236
11. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., and McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. Journal of Neuroscience 21 (2001) 2546-2552
12. Bartz J.A., and Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Hormones and Behavior 50 (2006) 518-528
13. Bartz J.A., and Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders. Progress in Brain Research 170 (2008) 451-462
14. Baumgartner T., Heinrichs M., Vonlanthen A., Fischbacher U., and Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 58 (2008) 639-650
15. Beckmann H., Lang R.E., and Gattaz W.F. Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 10 (1985) 187-191
16. Bell C.J., Nicholson H., Mulder R.T., Luty S.E., and Joyce P.R. Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence. Journal of Psychopharmacology 20 (2006) 656-660
17. Birbaumer N., Grodd W., Diedrich O., Klose U., Erb M., Lotze M., Schneider F., Weiss U., and Flor H. fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9 (1998) 1223-1226
18. Born J., Lange T., Kern W., McGregor G.P., Bickel U., and Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nature Neuroscience 5 (2002) 514-516
19. Boso M., Emanuele E., Politi P., Pace A., Arra M., Ucelli di Nemi S., and Barale F. Reduced plasma apelin levels in patients with autistic spectrum disorder. Archives of Medical Research 38 (2007) 70-74
20. A. Buchheim, M. Heinrichs, C. George, D. Pokorny, E. Koops, P. Henningsen, M.-F. O'Connor, H. Gündel, Oxytocin enhances the experience of attachment security, Psychoneuroendocrinology (2009), doi:10.1016/j.psyneuen.2009.04.002.
21. Bujanow W. Letter: is oxytocin an anti-schizophrenic hormone?. Canadian Psychiatric Association Journal 19 (1974) 323
22. Burri A., Heinrichs M., Schedlowski M., and Kruger T.H. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology 33 (2008) 591-600
23. Carter C.S. Developmental consequences of oxytocin. Physiology and Behavior 79 (2003) 383-397
24. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 23 (1998) 779-818
25. Carter C.S. Sex differences in oxytocin and vasopressin implications for autism spectrum disorders?. Behavioural Brain Research 176 (2007) 170-186
26. Carter C.S., and Altemus M. Integrative functions of lactational hormones in social behavior and stress management. Annals of the New York Academy of Sciences 807 (1997) 164-174
27. Carter C.S., Altemus M., and Chrousos G.P. Neuroendocrine and emotional changes in the post-partum period. Progress in Brain Research 133 (2001) 241-249
28. Carter C.S., Grippo A.J., Pournajafi-Nazarloo H., Ruscio M.G., and Porges S.W. Oxytocin vasopressin and sociality. Progress in Brain Research 170 (2008) 331-336
29. Carter C.S., Pournajafi-Nazarloo H., Kramer K.M., Ziegler T.E., White-Traut R., Bello D., and Schwertz D. Oxytocin behavioral associations and potential as a salivary biomarker. Annals of the New York Academy of Sciences 1098 (2007) 312-322
30. Charles G., Guillaume R., Schittecatte M., Pholien P., Van Wettere J.P., and Wilmotte J. Oxytocin in the treatment of obsessive-compulsive disorder: a report on two cases. Psychiatrie und Psychobiologie 4 (1989) 111-115
31. Chiodera P., Salvarani C., Bacchi-Modena A., Spallanzani R., Cigarini C., Alboni A., Gardini E., and Coiro V. Relationship between plasma profiles of oxytocin and adrenocorticotropic hormone during suckling or breast stimulation in women. Hormone Research 35 (1991) 119-123
32. Cho M.M., DeVries A.C., Williams J.R., and Carter C.S. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behavioral Neuroscience 113 (1999) 1071-1079
33. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., and Ferris C.F. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Archives of General Psychiatry 55 (1998) 708-714
34. Cyranowski J.M., Hofkens T.L., Frank E., Seltman H., Cai H.M., and Amico J.A. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosomatic Medicine 70 (2008) 967-975
35. Decaux G., Soupart A., and Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371 (2008) 1624-1632
36. den Boer J.A., and Westenberg H.G. Oxytocin in obsessive compulsive disorder. Peptides 13 (1992) 1083-1085
37. Di Simplicio M., Massey-Chase R., Cowen P., and Harmer C. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. Journal of Psychopharmacology 23 (2009) 241-248
38. Ditzen B., Neumann I.D., Bodenmann G., von Dawans B., Turner R.A., Ehlert U., and Heinrichs M. Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women. Psychoneuroendocrinology 32 (2007) 565-574
39. Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., and Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biological Psychiatry 65 (2009) 728-731
40. Ditzen B., Schmidt S., Strauss B., Nater U.M., Ehlert U., and Heinrichs M. Adult attachment and social support interact to reduce psychological but not cortisol responses to stress. Journal of Psychosomatic Research 64 (2008) 479-486
41. Dodt C., Pietrowsky R., Sewing A., Zabel A., Fehm H.L., and Born J. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans. Journal of Gerontology 49 (1994) M183-M188
42. Domes G., Czieschnek D., Weidler F., Berger C., Fast K., and Herpertz S.C. Recognition of facial affect in borderline personality disorder. Journal of Personality Disorders 22 (2008) 135-147
43. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., and Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry 62 (2007) 1187-1190
44. Domes G., Heinrichs M., Michel A., Berger C., and Herpertz S.C. Oxytocin improves "mind-reading" in humans. Biological Psychiatry 61 (2007) 731-733
45. Donaldson Z.R., and Young L.J. Oxytocin vasopressin and the neurogenetics of sociality. Science 322 (2008) 900-904
46. Donegan N.H., Sanislow C.A., Blumberg H.P., Fulbright R.K., Lacadie C., Skudlarski P., Gore J.C., Olson I.R., McGlashan T.H., and Wexler B.E. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biological psychiatry 54 (2003) 1284-1293
47. Epperson C.N., McDougle C.J., and Price L.H. Intranasal oxytocin in obsessive-compulsive disorder. Biological Psychiatry 40 (1996) 547-549
48. Epperson C.N., McDougle C.J., and Price L.H. Intranasal oxytocin in trichotillomania. Biological Psychiatry 40 (1996) 559-560
49. Ferris C.F., Lu S.F., Messenger T., Guillon C.D., Heindel N., Miller M., Koppel G., Robert Bruns F., and Simon N.G. Orally active vasopressin V1a receptor antagonist SRX251 selectively blocks aggressive behavior. Pharmacology Biochemistry and Behavior 83 (2006) 169-174
50. Frasch A., Zetzsche T., Steiger A., and Jirikowski G.F. Reduction of plasma oxytocin levels in patients suffering from major depression. Advances in Experimental Medicine and Biology 395 (1995) 257-258
51. Fries A.B., Ziegler T.E., Kurian J.R., Jacoris S., and Pollak S.D. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 17237-17240
52. Glovinsky D., Kalogeras K.T., Kirch D.G., Suddath R., and Wyatt R.J. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. Schizophrenia Research 11 (1994) 273-276
53. Goldman M., Marlow-O'Connor M., Torres I., and Carter C.S. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophrenia Research 98 (2008) 247-255
54. Goldman M.B., Robertson G.L., and Hedeker D. Oropharyngeal regulation of water balance in polydipsic schizophrenics. Clinical Endocrinology (Oxford) 44 (1996) 31-37
55. Goodson J.L., and Bass A.H. Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates. Brain Research 35 (2001) 246-265
56. Gordon I., Zagoory-Sharon O., Schneiderman I., Leckman J.F., Weller A., and Feldman R. Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress. Psychophysiology 45 (2008) 349-352
57. Green L., Fein D., Modahl C., Feinstein C., Waterhouse L., and Morris M. Oxytocin and autistic disorder: alterations in peptide forms. Biological Psychiatry 50 (2001) 609-613
58. Griebel G., Stemmelin J., Gal C.S., and Soubrie P. Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders. Current Pharmaceutical Design 11 (2005) 1549-1559
59. Guastella A.J., Carson D.S., Dadds M.R., Mitchell P.B., and Cox R.E. Does oxytocin influence the early detection of angry and happy faces?. Psychoneuroendocrinology 34 (2009) 220-225
60. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., and Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34 (2009) 917-923
61. Guastella A.J., Mitchell P.B., and Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biological Psychiatry 63 (2008) 3-5
62. Guastella A.J., Mitchell P.B., and Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biological Psychiatry 64 (2008) 256-258
63. Hammock E.A., and Young L.J. Oxytocin, vasopressin and pair bonding: implications for autism. Philosophical Transactions of the Royal Society of London 361 (2006) 2187-2198
64. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., and Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Molecular Psychiatry 112 (2008) 10.1038/mp.2008 (Epub ahead of print)
65. Heimberg R.G. Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biological Psychiatry 51 (2002) 101-108
66. Heinrichs M. Oxytocin and behavior: psychobiological effects of oxytocin on human cognitive performance and stress reactivity (2000), Cuvillier, Göttingen, Germany
67. Heinrichs M., Baumgartner T., Kirschbaum C., and Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry 54 (2003) 1389-1398
68. Heinrichs M., and Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Progress in Brain Research 170 (2008) 337-350
69. Heinrichs M., and Gaab J. Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders. Current Opinion in Psychiatry 20 (2007) 158-162
70. Heinrichs M., Meinlschmidt G., Neumann I., Wagner S., Kirschbaum C., Ehlert U., and Hellhammer D.H. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. Journal of Clinical Endocrinology and Metabolism 86 (2001) 4798-4804
71. Heinrichs M., Meinlschmidt G., Wippich W., Ehlert U., and Hellhammer D.H. Selective amnesic effects of oxytocin on human memory. Physiology and Behavior 83 (2004) 31-38
72. Heinrichs M., Neumann I., and Ehlert U. Lactation and stress: protective effects of breast-feeding in humans. Stress 5 (2002) 195-203
73. Herpertz S.C., Dietrich T.M., Wenning B., Krings T., Erberich S.G., Willmes K., Thron A., and Sass H. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biological psychiatry 50 (2001) 292-298
74. Herpertz S.C., Gretzer A., Steinmeyer E.M., Muehlbauer V., Schuerkens A., and Sass H. Affective instability and impulsivity in personality disorder. Results of an experimental study. Journal of Affective Disorders 44 (1997) 31-37
75. Hoge E.A., Pollack M.H., Kaufman R.E., Zak P.J., and Simon N.M. Oxytocin levels in social anxiety disorder. CNS Neuroscience Therapy 14 (2008) 165-170
76. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E., and Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry 61 (2007) 498-503
77. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., and Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28 (2003) 193-198
78. Holt-Lunstad J., Birmingham W.A., and Light K.C. Influence of a "warm touch" support enhancement intervention among married couples on ambulatory blood pressure oxytocin alpha amylase and cortisol. Psychosomatic Medicine 70 (2008) 976-985
79. Horvat-Gordon M., Granger D.A., Schwartz E.B., Nelson V.J., and Kivlighan K.T. Oxytocin is not a valid biomarker when measured in saliva by immunoassay. Physiology and Behavior 84 (2005) 445-448
80. Huber D., Veinante P., and Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308 (2005) 245-248
81. Ingram C.D., Adams T.S., Jiang Q.B., Terenzi M.G., Lambert R.C., Wakerley J.B., and Moos F. Mortyn Jones Memorial Lecture Limbic regions mediating central actions of oxytocin on the milk-ejection reflex in the rat. Journal of Neuroendocrinology 7 (1995) 1-13
82. Insel T.R. A neurobiological basis of social attachment. American Journal of Psychiatry 154 (1997) 726-735
83. Insel T.R. Oxytocin - a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 17 (1992) 3-35
84. Insel T.R., and Young L.J. The neurobiology of attachment. Nature Reviews Neuroscience 2 (2001) 129-136
85. Jacob S., Brune C.W., Carter C.S., Leventhal B.L., Lord C., and Cook Jr. E.H. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neuroscience Letters 417 (2007) 6-9
86. Jancke L. Facial EMG in an anger-provoking situation: individual differences in directing anger outwards or inwards. International Journal of Psychophysiology 23 (1996) 207-214
87. Kang Y.S., and Park J.H. Brain uptake and the analgesic effect of oxytocin - its usefulness as an analgesic agent. Archives of Pharmacal Research 23 (2000) 391-395
88. Keri S., Kiss I., and Kelemen O. Sharing secrets: oxytocin and trust in schizophrenia. Social Neuroscience (2008) 1-7
89. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., and Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51 (1994) 8-19
90. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., Courchesne E., Lord C., Leventhal B.L., Cook Jr. E.H., and Insel T.R. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Molecular Psychiatry 7 (2002) 503-507
91. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., and Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience 25 (2005) 11489-11493
92. Knafo A., Israel S., Darvasi A., Bachner-Melman R., Uzefovsky F., Cohen L., Feldman E., Lerer E., Laiba E., Raz Y., Nemanov L., Gritsenko I., Dina C., Agam G., Dean B., Bornstein G., and Ebstein R.P. Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes, Brain and Behavior 7 (2008) 266-275
93. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
94. Landgraf R., and Neumann I.D. Vasopressin and oxytocin release within the brain a dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology 25 (2004) 150-176
95. Lauritsen M.B., Als T.D., Dahl H.A., Flint T.J., Wang A.G., Vang M., Kruse T.A., Ewald H., and Mors O. A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands. Molecular Psychiatry 11 (2006) 37-46
96. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., Anderson G.M., Riddle M.A., McDougle C.J., Barr L.C., et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 19 (1994) 723-749
97. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., Anderson G.M., Riddle M.A., McSwiggan-Hardin M., McDougle C.J., et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Archives of General Psychiatry 51 (1994) 782-792
98. Legros J.J., Gazzotti C., Carvelli T., Franchimont P., Timsit-Berthier M., von Frenckell R., and Ansseau M. Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology 17 (1992) 611-617
99. Lerer E., Levi S., Salomon S., Darvasi A., Yirmiya N., and Ebstein R.P. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland adaptive behavior scales and cognition. Molecular Psychiatry 13 (2008) 980-988
100. Levine A., Zagoory-Sharon O., Feldman R., and Weller A. Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment. Peptides 28 (2007) 1162-1169
101. Levy K.N. The implications of attachment theory and research for understanding borderline personality disorder. Development and Psychopathology 17 (2005) 959-986
102. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 (2004) 453-461
103. Light K.C., Smith T.E., Johns J.M., Brownley K.A., Hofheimer J.A., and Amico J.A. Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity. Health Psychology 19 (2000) 560-567
104. Lim M.M., and Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Hormones and Behavior 50 (2006) 506-517
105. Linkowski P., Geenen V., Kerkhofs M., Mendlewicz J., and Legros J.J. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. European Archives of Psychiatry and Neurological Sciences 234 (1984) 162-165
106. Loup F., Tribollet E., Dubois-Dauphin M., and Dreifuss J.J. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Research 555 (1991) 220-232
107. Lumley L.A., Robison C.L., Chen W.K., Mark B., and Meyerhoff J.L. Vasopressin into the preoptic area increases grooming behavior in mice. Physiology and Behavior 73 (2001) 451-455
108. Mai J.K., Berger K., and Sofroniew M.V. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. Journal für Hirnforschung 34 (1993) 133-154
109. Marazziti D., and Catena Dell'osso M. The role of oxytocin in neuropsychiatric disorders. Current Medicinal Chemistry 15 (2008) 698-704
110. McCauley J.L., Li C., Jiang L., Olson L.M., Crockett G., Gainer K., Folstein S.E., Haines J.L., and Sutcliffe J.S. Genome-wide and ordered-subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Medical Genetics 6 (2005) 1
111. McEwen B.B. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Advances in Pharmacology 50 (2004) 531-592
112. Meinlschmidt G., and Heim C. Sensitivity to intranasal oxytocin in adult men with early parental separation. Biological Psychiatry 61 (2007) 1109-1111
113. Meyer-Lindenberg A., Kolachana B., Gold B., Olsh A., Nicodemus K.K., Mattay V., Dean M., and Weinberger D.R. Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Molecular Psychiatry 54 (2008) 10.1038/mp.2008 (Epub ahead of print)
114. Minzenberg M.J., Fan J., New A.S., Tang C.Y., and Siever L.J. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Research 155 (2007) 231-243
115. Modahl C., Green L., Fein D., Morris M., Waterhouse L., Feinstein C., and Levin H. Plasma oxytocin levels in autistic children. Biological Psychiatry 43 (1998) 270-277
116. Momeni N., Nordstrom B.M., Horstmann V., Avarseji H., and Sivberg B.V. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders. BMC Psychiatry 5 (2005) 27
117. Murgatroyd C., Wigger A., Frank E., Singewald N., Bunck M., Holsboer F., Landgraf R., and Spengler D. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. Journal of Neuroscience 24 (2004) 7762-7770
118. Murray J.B. Phencyclidine (PCP) a dangerous drug, but useful in schizophrenia research. Journal of Psychology 136 (2002) 319-327
119. Neumann I.D. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamic-pituitary-adrenal axis. Progress in Brain Research 139 (2002) 147-162
120. Neumann I.D., Kromer S.A., Toschi N., and Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamic-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regulatory peptides 96 (2000) 31-38
121. Neumann I.D., Wigger A., Torner L., Holsboer F., and Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamic-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. Journal of Neuroendocrinology 12 (2000) 235-243
122. Nissen E., Uvnas-Moberg K., Svensson K., Stock S., Widstrom A.M., and Winberg J. Different patterns of oxytocin, prolactin but not cortisol release during breastfeeding in women delivered by caesarean section or by the vaginal route. Early Human Development 45 (1996) 103-118
123. Parker K.J., Buckmaster C.L., Schatzberg A.F., and Lyons D.M. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology 30 (2005) 924-929
124. Pedersen C.A. Oxytocin control of maternal behavior Regulation by sex steroids and offspring stimuli. Annals of the New York Academy of Sciences 807 (1997) 126-145
125. Pedersen C.A., Caldwell J.D., Drago F., Noonan L.R., Peterson G., Hood L.E., and Prange Jr. A.J. Grooming behavioral effects of oxytocin. Pharmacology, ontogeny, and comparisons with other nonapeptides. Annals of the New York Academy of Sciences 525 (1988) 245-256
126. Peskind E.R., Raskind M.A., Leake R.D., Ervin M.G., Ross M.G., and Dorsa D.M. Clonidine decreases plasma and cerebrospinal fluid arginine vasopressin but not oxytocin in humans. Neuroendocrinology 46 (1987) 395-400
127. Petrovic P., Kalisch R., Singer T., and Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. Journal of Neuroscience 28 (2008) 6607-6615
128. Pierrehumbert B., Torrisi R., Glatz N., Dimitrova N., Heinrichs M., and Halfon O. The influence of attachment on perceived stress and cortisol response to acute stress in women sexually abused in childhood or adolescence. Psychoneuroendocrinology 34 (2009) 924-938
129. Pietrowsky R., Thiemann A., Kern W., Fehm H.L., and Born J. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 21 (1996) 559-572
130. Pitts A.F., Samuelson S.D., Meller W.H., Bissette G., Nemeroff C.B., and Kathol R.G. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biological Psychiatry 38 (1995) 330-335
131. Purba J.S., Hoogendijk W.J., Hofman M.A., and Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archives of General Psychiatry 53 (1996) 137-143
132. Raggenbass M. Vasopressin- and oxytocin-induced activity in the central nervous system: electrophysiological studies using in-vitro systems. Progress in Neurobiology 64 (2001) 307-326
133. Raskind M.A., Courtney N., Murburg M.M., Backus F.I., Bokan J.A., Ries R.K., Dorsa D.M., and Weitzman R.E. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. Biological Psychiatry 22 (1987) 453-462
134. Rimmele U., Hediger K., Heinrichs M., and Klaver P. Oxytocin makes a face in memory familiar. Journal of Neuroscience 29 (2009) 38-42
135. Salzberg A.D., and Swedo S.E. Oxytocin and vasopressin in obsessive-compulsive disorder. American Journal of Psychiatry 149 (1992) 713-714
136. Savaskan E., Ehrhardt R., Schulz A., Walter M., and Schachinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 33 (2008) 368-374
137. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., Ansseau M., and Legros J.J. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32 (2007) 407-410
138. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Pinto E., Reggers J., Ansseau M., and Legros J.J. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology 30 (2005) 839-845
139. Singer T., Snozzi R., Bird G., Petrovic P., Silani G., Heinrichs M., and Dolan R.J. Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 8 (2008) 781-791
140. Slattery D.A., and Neumann I.D. No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain. Journal of Physiology 586 (2008) 377-385
141. Surget A., and Belzung C. Involvement of vasopressin in affective disorders. European Journal of Pharmacology 583 (2008) 340-349
142. Swedo S.E., Leonard H.L., Kruesi M.J., Rettew D.C., Listwak S.J., Berrettini W., Stipetic M., Hamburger S., Gold P.W., Potter W.Z., et al. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry 49 (1992) 29-36
143. Thibonnier M., Graves M.K., Wagner M.S., Auzan C., Clauser E., and Willard H.F. Structure, sequence, expression, and chromosomal localization of the human V1a vasopressin receptor gene. Genomics 31 (1996) 327-334
144. Thompson R., Gupta S., Miller K., Mills S., and Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology 29 (2004) 35-48
145. Thompson R.R., George K., Walton J.C., Orr S.P., and Benson J. Sex-specific influences of vasopressin on human social communication. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 7889-7894
146. Turner R.A., Altemus M., Enos T., Cooper B., and McGuinness T. Preliminary research on plasma oxytocin in normal cycling women: investigating emotion and interpersonal distress. Psychiatry 62 (1999) 97-113
147. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 23 (1998) 819-835
148. Uvnas-Moberg K. Role of efferent and afferent vagal nerve activity during reproduction: integrating function of oxytocin on metabolism and behaviour. Psychoneuroendocrinology 19 (1994) 687-695
149. Uvnas-Moberg K., Bjokstrand E., Hillegaart V., and Ahlenius S. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology 142 (1999) 95-101
150. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., and De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17 (1997) 284-292
151. van Londen L., Goekoop J.G., Zwinderman A.H., Lanser J.B., Wiegant V.M., and De Wied D. Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression. Psychological Medicine 28 (1998) 275-284
152. van Londen L., Kerkhof G.A., van den Berg F., Goekoop J.G., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., and de Wied D. Plasma arginine vasopressin and motor activity in major depression. Biological Psychiatry 43 (1998) 196-204
153. Wagner A.W., and Linehan M.M. Facial expression recognition ability among women with borderline personality disorder: implications for emotion regulation?. Journal of Personality Disorders 13 (1999) 329-344
154. Walum H., Westberg L., Henningsson S., Neiderhiser J.M., Reiss D., Igl W., Ganiban J.M., Spotts E.L., Pedersen N.L., Eriksson E., and Lichtenstein P. Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proceedings of the National Academy of Sciences of the United States of America 105 (2008) 14153-14156
155. Wang S.S., Kamphuis W., Huitinga I., Zhou J.N., and Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Molecular Psychiatry 13 (2008) 786-799
156. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., Folstein S.E., and Sheffield V.C. Examination of AVPR1a as an autism susceptibility gene. Molecular Psychiatry 9 (2004) 968-972
157. White-Traut R., Watanabe K., Pournajafi-Nazarloo H., Schwertz D., Bell A., and Carter C.S. Detection of salivary oxytocin levels in lactating women. Development and Psychopathology 51 (2009) 367-373
158. Windle R.J., Kershaw Y.M., Shanks N., Wood S.A., Lightman S.L., and Ingram C.D. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamic-pituitary-adrenal activity. Journal of Neuroscience 24 (2004) 2974-2982
159. Windle R.J., Shanks N., Lightman S.L., and Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138 (1997) 2829-2834
160. Windle R.J., Wood S., Shanks N., Perks P., Conde G.L., da Costa A.P., Ingram C.D., and Lightman S.L. Endocrine and behavioural responses to noise stress: comparison of virgin and lactating female rats during non-disrupted maternal activity. Journal of Neuroendocrinology 9 (1997) 407-414
161. Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M., Gong X., Zhang Y., Yang X., and Zhang D. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biological Psychiatry 58 (2005) 74-77
162. Yirmiya N., Rosenberg C., Levi S., Salomon S., Shulman C., Nemanov L., Dina C., and Ebstein R.P. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Molecular Psychiatry 11 (2006) 488-494
163. Ylisaukko-oja T., Alarcon M., Cantor R.M., Auranen M., Vanhala R., Kempas E., von Wendt L., Jarvela I., Geschwind D.H., and Peltonen L. Search for autism loci by combined analysis of autism genetic resource exchange and Finnish families. Annals of Neurology 59 (2006) 145-155
164. Young L.J., Pitkow L.J., and Ferguson J.N. Neuropeptides and social behavior: animal models relevant to autism. Molecular Psychiatry 7 Suppl 2 (2002) S38-S39
165. Young L.J., and Wang Z. The neurobiology of pair bonding. Nature Neuroscience 7 (2004) 1048-1054
166. Zak P.J., Kurzban R., and Matzner W.T. The neurobiology of trust. Annals of the New York Academy of Sciences 1032 (2004) 224-227
167. Zak P.J., Kurzban R., and Matzner W.T. Oxytocin is associated with human trustworthiness. Hormones and Behavior 48 (2005) 522-527